RI
Ramakant Innani
About Ramakant Innani
Data last updated:
Ramakant Innani is a Director at Shilpa Pharma Lifesciences Limited (since 2020), Director at Inok Cottons Private Limited (since 2017) and Managing Director at Shilpa Biologicals Private Limited (since 2020), and holds 7 more current directorships. The companies operate in Pharma, Manufacturing and Real Estate and Construction. The 9 current companies with reported revenue have a combined latest revenue of ₹1,076 Cr; the largest is Shilpa Pharma Lifesciences Limited at ₹850 Cr (FY 2025). Earlier, Ramakant Innani was a Cfo at Raichem Medicare Private Limited (2015–2020) and Director at Mohiniradha Infra Private Limited (2010–2013) and 3 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 08 May 2020 | 2020 | ₹850 Cr (FY 2025) | Active | |
| Director | 15 Dec 2017 | 2017 | ₹104 Cr (FY 2025) | Active | |
| Managing Director | 09 Jan 2020 | 2020 | ₹85.24 Cr (FY 2025) | Active | |
| Director | 28 Feb 2019 | 2019 | ₹17.29 Cr (FY 2025) | Active | |
| Director | 17 Sep 2013 | 2013 | ₹11.43 Cr (FY 2025) | Active | |
| Director | 07 Sep 2011 | 2004 | ₹4.45 Cr (FY 2023) | Active | |
| Director | 09 Jan 2020 | 2020 | ₹1.28 Cr (FY 2025) | Active | |
| Director | 12 Feb 2016 | 2016 | ₹1.26 Cr (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Cfo | 05 Dec 2015 | 2009 | ₹515 Cr (FY 2025) | Active | |
| Director | 20 Dec 2010 | 2010 | ₹10.3 Lakh (FY 2025) | Active | |
| Director | 07 Mar 2018 | 2018 | ₹10,000 (FY 2024) | Strike Off | |
| Director | 22 Nov 2010 | 2009 | Strike Off | ||
| Director | 31 Mar 2020 | 2015 | ₹68.2 Lakh (FY 2024) | Amalgamated |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Ramakant Innani
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Ramakant Innani
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ramakant Innani
Ramakant Innani currently holds 10 directorships: Shilpa Pharma Lifesciences Limited (Director, since 08 May 2020, revenue ₹850 Cr (FY 2025)); Inok Cottons Private Limited (Director, since 15 Dec 2017, revenue ₹104 Cr (FY 2025)); Shilpa Biologicals Private Limited (Managing Director, since 09 Jan 2020, revenue ₹85.24 Cr (FY 2025)); Sravathi Advance Process Technologies Private Limited (Director, since 28 Feb 2019, revenue ₹17.29 Cr (FY 2025)); Jaijanaki Fabrics Private Limited (Director, since 17 Sep 2013, revenue ₹11.43 Cr (FY 2025)); and 5 more.
Ramakant Innani was first appointed on 22 Nov 2010 as Director at Reva Pharmachem Private Limited. The most recent appointment on record is 20 Jul 2021 at Shilpa Lifesciences Private Limited.
The 9 current companies of Ramakant Innani that report revenue have a combined latest revenue of ₹1,076 Cr: Shilpa Pharma Lifesciences Limited ₹850 Cr (FY 2025); Inok Cottons Private Limited ₹104 Cr (FY 2025); Shilpa Biologicals Private Limited ₹85.24 Cr (FY 2025); Sravathi Advance Process Technologies Private Limited ₹17.29 Cr (FY 2025); Jaijanaki Fabrics Private Limited ₹11.43 Cr (FY 2025); and 4 more.
Ramakant Innani held 5 earlier board appointments: Raichem Medicare Private Limited (Cfo, 05 Dec 2015 to 11 Jun 2020); Mohiniradha Infra Private Limited (Director, 20 Dec 2010 to 27 Dec 2013); Inm Nuvent Paints Private Limited (Director, from 07 Mar 2018); Reva Pharmachem Private Limited (Director, from 22 Nov 2010); Inm Technologies Private Limited (Director, from 31 Mar 2020).
The current boards of Ramakant Innani's companies include Alpesh Maheshkumar Dalal (Shilpa Pharma Lifesciences Limited), Anita Bandyopadhyay (Shilpa Pharma Lifesciences Limited), Kalakota Reddy Sharath (Shilpa Pharma Lifesciences Limited), Keshav Bhutada (Shilpa Pharma Lifesciences Limited), Keshav Bhutada (Shilpa Pharma Lifesciences Limited), Ritu Tiwary (Shilpa Pharma Lifesciences Limited), among others.